What are the first and second line treatments for strep (streptococcal) pharyngitis in a pediatric or young adult patient, including those with a penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First and Second Line Treatment for Strep Pharyngitis

First-Line Treatment

Penicillin or amoxicillin for 10 days remains the gold standard first-line treatment for strep pharyngitis in patients without penicillin allergy, due to proven efficacy, zero documented resistance worldwide, narrow spectrum, safety, and low cost. 1, 2

Specific Dosing Regimens

For pediatric patients:

  • Amoxicillin 50 mg/kg once daily (maximum 1000 mg) for 10 days is the preferred regimen due to enhanced adherence while maintaining equivalent efficacy 3
  • Alternative: Amoxicillin 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days 3
  • Penicillin V 250 mg twice daily for 10 days is also acceptable 4

For adults:

  • Penicillin or amoxicillin for 10 days, with specific dosing based on formulation 1, 2

Critical Treatment Duration

  • A full 10-day course is mandatory regardless of symptom resolution to achieve maximal pharyngeal eradication and prevent acute rheumatic fever 3, 1
  • Shortening the course by even a few days results in appreciable increases in treatment failure rates 1
  • Therapy can be safely postponed up to 9 days after symptom onset and still prevent acute rheumatic fever 3

Second-Line Treatment (Penicillin-Allergic Patients)

The choice of second-line antibiotic depends critically on the type of penicillin allergy—this distinction is essential for safe and effective treatment.

For Non-Immediate (Non-Anaphylactic) Penicillin Allergy

First-generation cephalosporins are the preferred second-line alternatives, with strong, high-quality evidence supporting their efficacy. 5, 3

Specific regimens:

  • Cephalexin 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days 5, 3
  • Cefadroxil 30 mg/kg once daily (maximum 1 gram) for 10 days 5, 3

Key safety consideration:

  • Cross-reactivity risk with first-generation cephalosporins is only 0.1% in patients with non-severe, delayed penicillin reactions 5

For Immediate/Anaphylactic Penicillin Allergy

Patients with immediate hypersensitivity reactions (anaphylaxis, angioedema, respiratory distress, or urticaria within 1 hour) must avoid ALL beta-lactam antibiotics, including cephalosporins, due to up to 10% cross-reactivity risk. 5, 3

Preferred alternative: Clindamycin

  • Clindamycin 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days 5, 3
  • Adults: 300 mg three times daily for 10 days 5
  • Clindamycin has strong, moderate-quality evidence with only ~1% resistance among Group A Streptococcus in the United States 5
  • Particularly effective in chronic carriers and treatment failures 5

Acceptable alternatives: Macrolides

  • Azithromycin 12 mg/kg once daily (maximum 500 mg) for 5 days 5, 3, 6

    • Only antibiotic requiring just 5 days due to prolonged tissue half-life 5
    • However, macrolide resistance is 5-8% in the United States 5
    • FDA label specifically notes: "Data establishing efficacy of azithromycin in subsequent prevention of rheumatic fever are not available" 6
  • Clarithromycin 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days 5, 3

    • Similar resistance concerns as azithromycin 5

Critical Pitfalls to Avoid

  • Never prescribe cephalosporins to patients with immediate/anaphylactic penicillin reactions due to 10% cross-reactivity risk 5, 3
  • Never shorten the 10-day course (except azithromycin's 5-day regimen) as this dramatically increases treatment failure and rheumatic fever risk 3, 1
  • Never use broad-spectrum cephalosporins (cefaclor, cefuroxime, cefixime, cefdinir, cefpodoxime) when narrow-spectrum first-generation agents are appropriate—they are more expensive and select for resistant flora 5, 3
  • Never use trimethoprim-sulfamethoxazole, tetracyclines, or sulfonamides as they are ineffective for Group A Streptococcus eradication 5, 3
  • Never use azithromycin as first-line therapy when penicillin or amoxicillin can be used—it should be reserved for documented penicillin allergy 5

Adjunctive Therapy

  • Acetaminophen or NSAIDs (ibuprofen) should be offered to all patients for moderate to severe symptoms or high fever 5, 3, 1
  • Aspirin must be avoided in children due to Reye syndrome risk 5, 3
  • Corticosteroids are not recommended as adjunctive therapy 5

Treatment Algorithm Summary

  1. Confirm diagnosis with rapid antigen detection test or throat culture before treating 1

  2. Assess for penicillin allergy:

    • No allergy: Amoxicillin 50 mg/kg once daily × 10 days (preferred) 3
    • Non-immediate allergy: Cephalexin 20 mg/kg twice daily × 10 days 5, 3
    • Immediate/anaphylactic allergy: Clindamycin 7 mg/kg three times daily × 10 days (preferred) or azithromycin 12 mg/kg once daily × 5 days 5, 3
  3. Ensure full treatment course completion (10 days for all except azithromycin) 3, 1

  4. Add analgesic therapy (acetaminophen or ibuprofen) for symptom control 5, 3, 1

References

Guideline

Treatment of Adult Strep Throat Without Allergies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxicillin Dosing for Streptococcal Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.